Serum ferritin is a different predictor from transfusion history for allogeneic transplantation outcome in patients with severe aplastic anemia

References

• Armand P, Kim HT, Virtanen JM, et al. Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis. Biol Blood Marrow Transplant. 2014;20(8):1248–1251. PubMed PMID: 24769316; PubMed Central PMCID: PMC4099413. doi:10.1016/j.bbmt.2014.04.024.
   PubMed Web of Science ®Google Scholar
• Grossekatthofer M, Guclu E. D, Lawitschka A, et al. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease. Ann Hematol. 2013;92(8):1121–1128. doi: 10.1007/s00277-013-1737-x
   PubMed Web of Science ®Google Scholar
• Pileggi C, Di Sanzo M, Mascaro V, et al. Role of serum ferritin level on overall survival in patients with myelodysplastic syndromes: results of a meta-analysis of observational studies. PloS One. 2017;12(6):e0179016. Epub 2017/06/18. PubMed PMID: 28622367; PubMed Central PMCID: PMCPmc5473533. doi:10.1371/journal.pone.0179016.
   PubMed Web of Science ®Google Scholar
• Peinemann F, Bartel C, Grouven U. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia. Cochrane Database Syst Rev. 2013;(7):Cd006407. Epub 2013/07/25. PubMed PMID: 23881658. doi:10.1002/14651858.CD006407.pub2.
   PubMed Web of Science ®Google Scholar
• Trottier BJ, Burns LJ, DeFor TE, et al. Association of iron overload with allogeneic hematopoietic cell transplantation outcomes: a prospective cohort study using R2-MRI-measured liver iron content. Blood. 2013;122(9):1678–1684. Epub 2013/06/20. PubMed PMID: 23777771; PubMed Central PMCID: PMCPmc3953015. doi:10.1182/blood-2013-04-499772.
   PubMed Web of Science ®Google Scholar
• Alessandrino EP, Della Porta MG, Bacigalupo A, et al. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica. 2010;95(3):476–484. Epub 2009/11/12. PubMed PMID: 19903678; PubMed Central PMCID: PMCPmc2833079. doi:10.3324/haematol.2009.011429.
   PubMed Web of Science ®Google Scholar
• Pullarkat V, Blanchard S, Tegtmeier B, et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2008;42(12):799–805. Epub 2008/09/03. PubMed PMID: 18762767. doi:10.1038/bmt.2008.262.
   PubMed Web of Science ®Google Scholar
• Platzbecker U, Bornhauser M, Germing U, et al. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS). Biol Blood Marrow Transplant. 2008;14(11):1217–1225. Epub 2008/10/23. PubMed PMID: 18940675; PubMed Central PMCID: PMCPmc2759308. doi:10.1016/j.bbmt.2008.08.006.
   PubMed Web of Science ®Google Scholar
• Lim ZY, Fiaccadori V, Gandhi S, et al. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Leuk Res. 2010;34(6):723–727. Epub 2009/12/01. PubMed PMID: 19944463. doi:10.1016/j.leukres.2009.10.028.
   PubMed Web of Science ®Google Scholar
• Atilla E, Toprak SK, Demirer T. Current review of iron overload and related complications in hematopoietic stem cell transplantation. Turk J Haematol. 2017;34(1):1–9. Epub 2016/12/14. PubMed PMID: 27956374; PubMed Central PMCID: PMCPmc5451667. doi:10.4274/tjh.2016.0450.
   PubMed Web of Science ®Google Scholar
• Armand P, Kim HT, Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood. 2007;109(10):4586–4588. Epub 2007/01/20. PubMed PMID: 17234738; PubMed Central PMCID: PMCPmc1885508. doi:10.1182/blood-2006-10-054924.
   PubMed Web of Science ®Google Scholar
• Mahindra A, Bolwell B, Sobecks R, et al. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2009;146(3):310–316. Epub 2009/06/11. PubMed PMID: 19508292. doi:10.1111/j.1365-2141.2009.07774.x.
   PubMed Web of Science ®Google Scholar
• Wermke M, Schmidt A, Middeke JM, et al. MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation. Clin Cancer Res. 2012;18(23):6460–6468. Epub 2012/09/20. PubMed PMID: 22991415. doi:10.1158/1078-0432.ccr-12-1683.
   PubMed Web of Science ®Google Scholar
• Armand P, Kim HT, Rhodes J, et al. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(6):852–860. Epub 2010/09/22. PubMed PMID: 20854920; PubMed Central PMCID: PMCPmc3954514. doi:10.1016/j.bbmt.2010.09.006.
   PubMed Web of Science ®Google Scholar
• Virtanen JM, Itala-Remes MA, Remes KJ, et al. Prognostic impact of pretransplant iron overload measured with magnetic resonance imaging on severe infections in allogeneic stem cell transplantation. Eur J Haematol. 2013;91(1):85–93. Epub 2013/04/17. PubMed PMID: 23586843. doi:10.1111/ejh.12123.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Kanamori H, Matsumoto K, et al. Clinical significance of pretransplant serum ferritin on the outcome of allogeneic hematopoietic SCT: a prospective cohort study by the Kanto study group for cell therapy. Bone Marrow Transplant. 2015;50(5):727–733. Epub 2015/03/03. PubMed PMID: 25730191. doi:10.1038/bmt.2015.17.
   PubMed Web of Science ®Google Scholar
• Vaughn JE, Storer BE, Armand P, et al. Design and validation of an augmented hematopoietic cell transplantation-comorbidity index comprising pretransplant ferritin, albumin, and platelet count for prediction of outcomes after allogeneic transplantation. Biol Blood Marrow Transplant. 2015;21(8):1418–1424. Epub 2015/04/12. PubMed PMID: 25862589; PubMed Central PMCID: PMCPmc4506728. doi:10.1016/j.bbmt.2015.04.002.
   PubMed Web of Science ®Google Scholar
• Lee SE, Yahng SA, Cho BS, et al. Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia. Bone Marrow Transplant. 2016;51(10):1323–1329. Epub 2016/05/24. PubMed PMID: 27214082. doi:10.1038/bmt.2016.140.
   PubMed Web of Science ®Google Scholar
• Porter JB. Practical management of iron overload. Br J Haematol. 2001;115(2):239–252. Epub 2001/11/13. PubMed PMID: 11703317. doi: 10.1046/j.1365-2141.2001.03195.x
   PubMed Web of Science ®Google Scholar
• Lee JW. Iron chelation therapy in the myelodysplastic syndromes and aplastic anemia: a review of experience in South Korea. Int J Hematol. 2008;88(1):16–23. Epub 2008/07/08. PubMed PMID: 18604581; PubMed Central PMCID: PMCPmc2516545. doi:10.1007/s12185-008-0117-0.
   PubMed Web of Science ®Google Scholar
• Estcourt LJ, Malouf R, Trivella M, et al. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support. Cochrane Database Syst Rev. 2017;1:Cd011305. Epub 2017/01/28. PubMed PMID: 28128441; PubMed Central PMCID: PMCPmc5298168. doi:10.1002/14651858.CD011305.pub2.
   PubMedGoogle Scholar
• Hilken A, Langebrake C, Wolschke C, et al. Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT). Ann Hematol. 2017;96(8):1379–1388. Epub 2017/06/07. PubMed PMID: 28585071. doi:10.1007/s00277-017-3034-6.
   PubMed Web of Science ®Google Scholar
• Jin P, Wang J, Li X, et al. Evolution of iron burden in acquired aplastic anemia: a cohort study of more than 3-year follow-up. Int J Hematol. 2015;101(1):13–22. Epub 2014/11/29. PubMed PMID: 25430083. doi:10.1007/s12185-014-1708-6.
   PubMed Web of Science ®Google Scholar
• Bazuaye GN, Buser A, Gerull S, et al. Prognostic impact of iron parameters in patients undergoing allo-SCT. Bone Marrow Transplant. 2012;47(1):60–64. doi: 10.1038/bmt.2011.13
   PubMed Web of Science ®Google Scholar
• Sakamoto S, Kawabata H, Kanda J, et al. Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Int J Hematol. 2013;97(1):109–116. doi: 10.1007/s12185-012-1229-0
   PubMed Web of Science ®Google Scholar
• Speeckaert MM, Speeckaert R, Delanghe JR. Biological and clinical aspects of soluble transferrin receptor. Crit Rev Clin Lab Sci. 2010;47(5–6):213–228. Epub 2011/03/12. PubMed PMID: 21391831. doi:10.3109/10408363.2010.550461.
   PubMed Web of Science ®Google Scholar